• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Replies
5
Views
865
Replies
7
Views
561
Replies
16
Views
2K
Replies
12
Views
1K
Replies
4K
Views
1M